Main Article Content
Objective: This is a literature review that aims to present oral manifestation, medical considerations, dental considerations, prescribed medications of minor oral surgery for patients on Hemodialysis
Methods: The data were searched by website PubMed, Cochrane, google, journal of medicine and dentistry which the last search was conducted in November 2018.
Result: The data were from experimental study, prospective, double-blind, randomized controlled, clinical trial and case report. Oral lesions are rarely seen in patients with end stage renal disease undergoing hemodialysis. These causes from urea that was eliminated by dialyzer, but dehydration and medications can induce these occurred. Heparin has half-life about four hours, must be clear up from circulation before dentists provide minor oral surgery. Therefore, Invasive treatment should be done on the day after hemodialysis and complete blood count were done. Also, coagulation test needs to be determined in order to prevent excessive bleeding. Local anesthesia can be used safely. Paracetamol is a choice for pain management, and also tramadol is preferred in the case of severe analgesic. There are various antibiotics that require dose adjustment .Clindamycin, penicillin and its derivatives are safer antibiotics for hemodialysis patients.
Conclusion: In the past few years, several technological innovations in hemodialysis equipment have been developed, including new modalities and strategies that have been introduced. However, in the case of minor oral surgery in patients with end stage renal disease undergoing hemodialysis, dentists should concern about complication that may have occurred especially excessive bleeding and oral infection. Risk assessment, specific problems of patients undergoing hemodialysis should be identified and discussed with nephrologist prior invasive dental treatment. These will reduce the risk of possible complications.
Key word: hemodialysis, minor oral surgery, end stage renal disease, heparin, invasive treatment
How to cite: Jeenjanya P, Rummasak D. Dental Management of Minor oral surgery for Patients on Hemodialysis
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
1. Saran R, Robinson B, Abbott KC, Agodoa LY, Bragg-Gresham J, Balkrishnan R, et al. US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States. Elsevier; 2018.
2. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017; 389(10075): 1238-52.
3. Cerveró AJ, Bagán JV, Soriano YJ, Roda RP. Dental management in renal failure: patients on dialysis. Med Oral Patol Oral Cir Bucal 2008; 13(7): E419-26.
4. Dencheva M, Deliverska E, Krasteva A, Galabov J, Kisselova A. Aspects of Renal Disease Affecting Dental Management—Surgery in Patients Receiving Hemodyalisis. Updates in Hemodialysis: InTech; 2015.
5. Proctor R, Kumar N, Stein A, Moles D, Porter S. Oral and dental aspects of chronic renal failure. J Dent Res 2005; 84(3): 199-208.
6. Kho H-S, Lee S-W, Chung S-C, Kim Y-K. Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. ORAL SURG ORAL MED O 1999; 88(3): 316-9.
7. Bots CP, Poorterman JH, Brand HS, Kalsbeek H, Van Amerongen B, Veerman E, et al. The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Dis 2006; 12(2): 176-80.
8. Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, Van Amerongen BM, Valentijn RM, et al. Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int 2004; 66(4): 1662-8.
9. Yadav A, Deepak U, Misra N, Shiva Kumar G, Kaur A. Oral manifestations in renal failure patients undergoing Dialysis. Int J Med Sci Public Health 2015; 4(7): 1015-8.
10. Prince MR, Zhang H, Morris M, MacGregor JL, Grossman ME, Silberzweig J, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 2008; 248(3): 807-16.
11. De Rossi SS, Glick M. Dental considerations for the patient with renal disease receiving hemodialysis. J Am Dent Assoc 1996; 127(2): 211-9.
12. Carpenter WM, Cox DP. Kidney Disease. The ADA Practical Guide to Patients with Medical Conditions. 2015: 101-19.
13. Lockhart PB, Loven B, Brennan MT, Fox PC. The evidence base for the efficacy of antibiotic prophylaxis in dental practice. J Am Dent Assoc 2007; 138(4): 458-74
14. Venkatesan AM, Kundu S, Sacks D, Wallace MJ, Wojak JC, Rose SC, et al. Practice guideline for adult antibiotic prophylaxis during vascular and interventional radiology procedures. J Vasc Interv Radiol 2010; 21(11): 1611-30.
15. Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 1997; 30(4): 521-4.
16. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, et al. Nonvalvular cardiovascular device–related infections. Circulation 2003; 108(16): 2015-31.
17. Davenport A. Low‐molecular‐weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology 2009; 14(5): 455-61.
18. Gerberding JL. Management of occupational exposures to blood-borne viruses.
N Engl J Med 1995; 332(7): 444-51.
19. AFFAIRS ACOS, PRACTICE ACOD. Infection control recommendations for the dental office and the dental laboratory. J Am Dent Assoc 1996; 127(5): 672-80.
20. Pai AB, Cardone KE, Manley HJ, Peter WLS, Shaffer R, Somers M, et al. Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach. J Am Soc Nephrol 2013; 8(11): 1988-99.
21. Matzke GR, Aronoff GR, Atkinson Jr AJ, Bennett WM, Decker BS, Eckardt K-U, et al. Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011; 80(11): 1122-37.
22. Smyth B, Jones C, Saunders J. Prescribing for patients on dialysis. Aust Prescr 2016; 39(1): 21.
23. Harisingani R, Saad M, Cassagnol BM. How to Manage Pain in Patients with Renal Insufficiency or End-Stage Renal Disease on Dialysis? Hospitalist 2013; 2013(8).
24. Izzedine H, Launay-Vacher V, Abbara C, Aymard G, Bassilios N, Deray G. Pharmacokinetics of tramadol in a hemodialysis patient. Nephron 2002; 92(3): 755-6.
25. Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int 2004; 65(6): 2419-25.
26. Palmer BF, Alpern RJ, Floege J. Comprehensive clinical nephrology. 2010.
27. Kerr AR. Update on renal disease for the dental practitioner. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92(1): 9-16.
28. Brockmann W, Badr M. Chronic kidney disease: pharmacological considerations for the dentist. J Am Dent Assoc 2010; 141(11): 1330-9.
29. Lau A, Chang C, Sabatini S. Hemodialysis clearance of metronidazole and its metabolites. Antimicrob Agents Chemother 1986; 29(2): 235-8.
30. Livornese JL, Benz RL, Ingerman MJ, Santoro J. Antibacterial agents in renal failure. Infect Dis Clin North Am 1995; 9(3): 591-614.
31. Klassen JT, Krasko BM. The dental health status of dialysis patients. J Can Dent Assoc 2002; 68(1): 34-8.
32. Costantinides F, Castronovo G, Vettori E, Frattini C, Artero ML, Bevilacqua L, et al. Dental Care for Patients with End-Stage Renal Disease and Undergoing Hemodialysis. Int J Dent 2018; 2018.
33. Georgakopoulou EA, Achtari MD, Afentoulide N. Dental management of patients before and after renal transplantation. Stomatologija 2011; 13(4): 107-12.